Home » Newsletters » BioWorld Science

BioWorld Science

June 19, 2001

View Archived Issues

Candidate mucin production inhibitor presented at ATS 2001

Long-term efficacy and safety data for adalimumab discussed at EULAR 2001

Third phase II trial of LDP-341 begins

Pharming's rhC1 inhibitor granted orphan drug designation from EMEA

InterMune licenses Infergen from Amgen

Anakinra can arrest joint destruction in active rheumatoid arthritis

MIF antagonists and their potential therapeutic application patented by PIMR researchers

Worldwide clinical development program for Generx to be launched

Kaken presents new compounds acting as VLA-4 antagonists

New MMP and TNF-alpha production inhibitors designed by Ajinomoto scientists

Succinic acid derivatives useful for potentiating activity of beta-lactam antibiotics

Naturally produced antiproliferative compounds discovered by CNRS team

Pyrazolone-based kinase inhibitors reported in recent patent by Cephalon

Exploratory trial of IC-351 in female sexual arousal disorder shows no conclusive treatment effect

Milkhaus expands clinical testing of BPH agent

PEG sTNF-RI produces significant improvement in signs, symptoms and HRQOL in RA patients

ImClone reaches second milestone in phase III evaluation of BEC2

Metvix PDT receives first approval in Sweden

Recombinant urate oxidase now available for acute tumor lysis syndrome

Cardioprotective properties demonstrated for LU-135252 in infarcted SHSRP

Novartis seeks E.U. approval of Elidel atopic dermatitis treatment

Receptor subtype-selective muscarinic agonist compares favorably with pilocarpine in primates

Solvay commences Canadian study of Teveten in combination with home blood pressure monitoring

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...